Table 2.

Overall and breast cancer hazard ratios of being in the group AS, AS1, or AS2 vs. GCC.

Group	Overall survival		Breast cancer survival
	Original	Weighted	Original	Weighted
Follow-up from the date of diagnosis
AS	2.39 (2.09, 2.72)	1.31 (1.24, 1.38)	4.13 (2.72, 6.28)	2.15 (1.76, 2.63)
AS1	1.77 (1.49, 2.09)	0.99 (0.93, 1.05)	2.17 (1.15, 4.07)	0.81 (0.62, 1.05)
AS1’		1.17 (1.11, 1.24)		1.04 (0.83, 1.32)
AS2	4.92 (4.01, 6.03)	3.54 (3.29, 3.82)	11.84 (6.90,20.31)	10.73 (8.63,13.35)
AS2’		1.54 (1.46, 1.63)		6.85 (5.76, 8.15)
Follow-up from 1 year after the date of diagnosis
AS	2.08 (1.79, 2.42)	1.37 (1.29, 1.45)	3.91 (2.48, 6.18)	2.36 (1.91, 2.91)
AS1	1.65 (1.38, 1.99)	1.08 (1.02, 1.15)	2.18 (1.12, 4.24)	0.94 (0.72, 1.23)
AS1’		1.09 (1.03, 1.16)		1.14 (0.90, 1.45)
AS2	3.95 (3.08, 5.05)	3.36 (3.10, 3.63)	11.26 (6.14,20.64)	11.16 (8.89,14.01)
AS2’		1.36 (1.29, 1.45)		3.57 (2.94, 4.35)

“AS1”, “AS2” – estimates are obtained using recalculation of the weights for direct pseudorandomization of AS1 vs. GCC and AS2 vs. GCC.